AI Article Synopsis

  • Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system, and microRNAs are crucial in its pathophysiology.
  • The study analyzed the expression levels of specific microRNAs (miR-34a, miR-199a, miR-30c, and miR-19a) in CD4+ T cells from patients with relapsing-remitting MS compared to healthy individuals.
  • Results showed that certain microRNAs had higher expression during the relapsing phase of MS, indicating their potential role in T cell differentiation crucial for the disease's progression.

Article Abstract

Background: Multiple sclerosis is an immune-mediated inflammatory disease of central nervous system. MicroRNAs play important roles in autoimmune diseases such as MS.

Objectives: The aim was to evaluate the expression pattern of miR-34a, miR-199a, miR-30c and miR-19a in peripheral blood derived CD4+ T lymphocytes of both relapsing and remitting phases of MS.

Methods: Blood samples from 40 RRMS patients (20 in relapsing and 20 in remitting phase) and 20 healthy volunteers were taken. CD4+ T cells were isolated. The expression level of miR-34a, miR-199a, miR-30c and miR-19a, and the percentage of Th17 and Treg cells were measured. Expression of master transcription factors of Th17 and Treg cells and several targets of these miRNAs were also evaluated.

Results: Data indicated an increased expression of miR-34a, miR-30c and miR-19a in relapsing phase and decreased expression of miR-199a in remitting phase. ROC curve data add other prestigious information of miR-34a, miR-199a, miR-30c and miR-19a by defining relapsing and remitting phase and also healthy cases with high specificity and sensitivity at a proposed optimum cut-off point.

Conclusion: Collectively, we showed a correlation between the four miRNAs with different phases of MS and their possible involvement in differentiation pathways of Th17 cells, as the most important players in MS.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gene.2018.03.035DOI Listing

Publication Analysis

Top Keywords

mir-30c mir-19a
20
mir-34a mir-199a
16
mir-199a mir-30c
16
relapsing remitting
12
remitting phase
12
expression mir-34a
8
mir-19a peripheral
8
peripheral blood
8
multiple sclerosis
8
phase healthy
8

Similar Publications

Recent studies have demonstrated that exosomal microRNAs (miRNAs) have the potential of facilitating molecular diagnosis. Currently, little is known about the underlying mechanism behind late-onset acute graft-versus-host disease (LA GVHD). Identifying differentially expressed miRNAs in exosomes should be useful for understanding the role of miRNAs in this disease.

View Article and Find Full Text PDF
Article Synopsis
  • Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system, and microRNAs are crucial in its pathophysiology.
  • The study analyzed the expression levels of specific microRNAs (miR-34a, miR-199a, miR-30c, and miR-19a) in CD4+ T cells from patients with relapsing-remitting MS compared to healthy individuals.
  • Results showed that certain microRNAs had higher expression during the relapsing phase of MS, indicating their potential role in T cell differentiation crucial for the disease's progression.
View Article and Find Full Text PDF

miRNA expression over different time periods (24 and 48 h) using the quantitative RT-PCR and deep sequencing has been evaluated in a model of photochemically induced thrombosis. A combination of two approaches allowed us to determine the miRNA expression patterns caused by ischemia. Nine miRNAs, including let-7f-5p, miR-221-3p, miR-21-5p, miR-30c-5p, miR-30a-3p, miR-223-3p, miR-23a-3p, miR-22-5p, and miR-99a-5p, were differentially expressed in brain tissue and leukocytes of rats 48 h after onset of ischemia.

View Article and Find Full Text PDF

Comparative analysis of EV isolation procedures for miRNAs detection in serum samples.

J Extracell Vesicles

June 2016

Unidad de Investigación, Hospital Santa Cristina, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain.

Extracellular vesicles (EVs) are emerging as potent non-invasive biomarkers. However, current methodologies are time consuming and difficult to translate to clinical practice. To analyse EV-encapsulated circulating miRNA, we searched for a quick, easy and economic method to enrich frozen human serum samples for EV.

View Article and Find Full Text PDF

MicroRNAs are a class of small non-coding RNA that regulate gene expression at a post-transcriptional level. MicroRNAs have been identified in various body fluids under normal conditions and their stability as well as their dysregulation in disease opens up a new field for biomarker study. However, diurnal and day-to-day variation in plasma microRNA levels, and differential regulation between males and females, may affect biomarker stability.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!